Tuesday, March 29, 2011
Up to one in 10 women could benefit from anti-cancer treatments such as tamoxifen even before they show signs of the disease, according to an international panel of experts.
But there are concerns the drug could have side-effects, such as blood clots and, in some cases, womb cancer.
In a paper published today in The Lancet Oncology, the specialists call for a radical new approach to identifying and treating patients who are at risk.'
This 'International Panel of Experts' is lead by Professor Jack Cusick of the Wolfson Institute, an organisation funded by the Rothschilds, City of London Corporation and a plethora of Big Pharma Companies.
No conflict of interest there then!!
See here... and here...
Posted by DotConnector at 09:04